Evaluation and treatment of chagas disease in the United States: a systematic review.

By C. Bern, S. Montgomery, B. Herwaldt, A. Rassi, J. Marin-Neto, R. Dantas, J. Maguire, H. Acquatella, C. Morillo, L. Kirchhoff and 4 more. Journal of the American Medical Association (JAMA), 2007

771 citations recorded by the source corpus.

Subfields: Epidemiology, Physiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/c2d7fbbc430030e2bf424afda61ea2476e842db7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Baron
2. Sonia A. Kjos
3. J. Miller
4. M. Yabsley
5. C. Bern
6. M. Weinstein
7. S. Montgomery
8. S. Richter

Citations in the corpus

• Chagas' Disease. (2015, neutral): “* This is the standard regimen in published recommendations.(22) Some investigators treat adults with 300 mg per day for 60 days, regardless of body weight,(49) whereas others use an upper limit of 300 mg per day but prolong treatment to complete the total dose corresponding to 5 mg per kilogram per”
• Trypanosoma cruzi and Chagas' Disease in the United States (2011, background): “There is currently a growing movement to offer treatment to older patients and those with early cardiomyopathy (30, 302, 311).”
• A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a (2013, background): “There is an infection hazard from live organism in blood specimens [246, 248, 249].”